ID   MK14_HUMAN              Reviewed;         360 AA.
AC   Q16539; A6ZJ92; A8K6P4; B0LPH0; O60776; Q13083; Q14084; Q8TDX0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-NOV-2010, entry version 136.
DE   RecName: Full=Mitogen-activated protein kinase 14;
DE            Short=MAP kinase 14;
DE            Short=MAPK 14;
DE            EC=2.7.11.24;
DE   AltName: Full=Cytokine suppressive anti-inflammatory drug-binding protein;
DE            Short=CSAID-binding protein;
DE            Short=CSBP;
DE   AltName: Full=MAP kinase MXI2;
DE   AltName: Full=MAX-interacting protein 2;
DE   AltName: Full=Mitogen-activated protein kinase p38 alpha;
DE            Short=MAP kinase p38 alpha;
DE   AltName: Full=SAPK2A;
GN   Name=MAPK14; Synonyms=CSBP, CSBP1, CSBP2, CSPB1, MXI2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS CSBP1 AND CSBP2), AND PARTIAL
RP   PROTEIN SEQUENCE.
RC   TISSUE=Peripheral blood;
RX   MEDLINE=95089812; PubMed=7997261; DOI=10.1038/372739a0;
RA   Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S.,
RA   Green D., McNulty D., Blumenthal M.J., Heys R.J., Landvatter S.W.,
RA   Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P.,
RA   White J.R., Adams J.L., Young P.R.;
RT   "A protein kinase involved in the regulation of inflammatory cytokine
RT   biosynthesis.";
RL   Nature 372:739-746(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CSBP2).
RC   TISSUE=Liver;
RX   MEDLINE=95210359; PubMed=7696354; DOI=10.1016/0167-4889(95)00002-A;
RA   Han J., Richter B., Li Z., Kravchenko V.V., Ulevitch R.J.;
RT   "Molecular cloning of human p38 MAP kinase.";
RL   Biochim. Biophys. Acta 1265:224-227(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MXI2).
RX   MEDLINE=96068649; PubMed=7479834; DOI=10.1073/pnas.92.23.10531;
RA   Zervos A.S., Faccio L., Gatto J.P., Kyriakis J.M., Brent R.;
RT   "Mxi2, a mitogen-activated protein kinase that recognizes and
RT   phosphorylates Max protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10531-10534(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CSBP2).
RC   TISSUE=B-cell;
RX   MEDLINE=20189614; PubMed=10727080;
RA   Herbison C.E., Sayer D.C., Bellgard M., Allcock R.J.N.,
RA   Christiansen F.T., Price P.;
RT   "Structure and polymorphism of two stress-activated protein kinase
RT   genes centromeric of the MHC: SAPK2a and SAPK4.";
RL   DNA Seq. 10:229-243(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EXIP), AND ENZYME REGULATION.
RC   TISSUE=Renal cell carcinoma;
RX   MEDLINE=21855908; PubMed=11866441; DOI=10.1006/bbrc.2002.6529;
RA   Sudo T., Yagasaki Y., Hama H., Watanabe N., Osada H.;
RT   "Exip, a new alternative splicing variant of p38 alpha, can induce an
RT   earlier onset of apoptosis in HeLa cells.";
RL   Biochem. Biophys. Res. Commun. 291:838-843(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CSBP2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CSBP2).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CSBP2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-10.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [14]
RP   PROTEIN SEQUENCE OF 174-186.
RX   MEDLINE=95007754; PubMed=7923354; DOI=10.1016/0092-8674(94)90278-X;
RA   Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S.,
RA   Hsuan J., Saklatvala J.;
RT   "Interleukin-1 activates a novel protein kinase cascade that results
RT   in the phosphorylation of Hsp27.";
RL   Cell 78:1039-1049(1994).
RN   [15]
RP   MUTAGENESIS OF ALA-34; LYS-53; ASP-168; THR-175; THR-180 AND TYR-182.
RX   MEDLINE=96094282; PubMed=7493921; DOI=10.1074/jbc.270.49.29043;
RA   Kumar S., McLaughlin M.M., McDonnell P.C., Lee J.C., Livi G.P.,
RA   Young P.R.;
RT   "Human mitogen-activated protein kinase CSBP1, but not CSBP2,
RT   complements a hog1 deletion in yeast.";
RL   J. Biol. Chem. 270:29043-29046(1995).
RN   [16]
RP   FUNCTION.
RC   TISSUE=Hepatoma;
RX   MEDLINE=20397758; PubMed=10943842; DOI=10.1016/S0092-8674(00)00027-1;
RA   Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M.;
RT   "Requirement for p38alpha in erythropoietin expression: a role for
RT   stress kinases in erythropoiesis.";
RL   Cell 102:221-231(2000).
RN   [17]
RP   FUNCTION (ISOFORM MXI2), COFACTOR, AND ENZYME REGULATION.
RX   MEDLINE=20298665; PubMed=10838079; DOI=10.1016/S0014-5793(00)01598-2;
RA   Sanz V., Arozarena I., Crespo P.;
RT   "Distinct carboxy-termini confer divergent characteristics to the
RT   mitogen-activated protein kinase p38alpha and its splice isoform
RT   Mxi2.";
RL   FEBS Lett. 474:169-174(2000).
RN   [18]
RP   MUTAGENESIS OF TYR-69; ASP-176; ASP-177; ALA-320; PHE-327 AND TRP-337.
RX   PubMed=15284239; DOI=10.1074/jbc.M404595200;
RA   Diskin R., Askari N., Capone R., Engelberg D., Livnah O.;
RT   "Active mutants of the human p38alpha mitogen-activated protein
RT   kinase.";
RL   J. Biol. Chem. 279:47040-47049(2004).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=16083285; DOI=10.1021/pr050048h;
RA   Kim J.-E., Tannenbaum S.R., White F.M.;
RT   "Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
RL   J. Proteome Res. 4:1339-1346(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   INTERACTION WITH FAM48A.
RX   PubMed=16751104; DOI=10.1016/j.cell.2006.03.048;
RA   Zohn I.E., Li Y., Skolnik E.Y., Anderson K.V., Han J., Niswander L.;
RT   "p38 and a p38-interacting protein are critical for downregulation of
RT   E-cadherin during mouse gastrulation.";
RL   Cell 125:957-969(2006).
RN   [23]
RP   INTERACTION WITH NP60.
RX   PubMed=16352664; DOI=10.1242/jcs.02699;
RA   Fu J., Yang Z., Wei J., Han J., Gu J.;
RT   "Nuclear protein NP60 regulates p38 MAPK activity.";
RL   J. Cell Sci. 119:115-123(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-263, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-16; THR-180 AND
RP   TYR-182, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-180 AND TYR-182,
RP   AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   MEDLINE=97066959; PubMed=8910361; DOI=10.1074/jbc.271.44.27696;
RA   Wilson K.P., Fitzgibbon M.J., Caron P.R., Griffith J.P., Chen W.,
RA   McCaffrey P.G., Chambers S.P., Su M.S.-S.;
RT   "Crystal structure of p38 mitogen-activated protein kinase.";
RL   J. Biol. Chem. 271:27696-27700(1996).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE=97249295; PubMed=9095200; DOI=10.1038/nsb0497-311;
RA   Tong L., Pav S., White D.M., Rogers S., Crane K.M., Cywin C.L.,
RA   Brown M.L., Pargellis C.A.;
RT   "A highly specific inhibitor of human p38 MAP kinase binds in the ATP
RT   pocket.";
RL   Nat. Struct. Biol. 4:311-316(1997).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   MEDLINE=98428668; PubMed=9753691; DOI=10.1016/S0969-2126(98)00113-0;
RA   Wang Z., Canagarajah B.J., Boehm J.C., Kassisa S., Cobb M.H.,
RA   Young P.R., Abdel-Meguid S., Adams J.L., Goldsmith E.J.;
RT   "Structural basis of inhibitor selectivity in MAP kinases.";
RL   Structure 6:1117-1128(1998).
RN   [38]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-51; ARG-322 AND GLY-343.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Responds to activation by environmental stress, pro-
CC       inflammatory cytokines and lipopolysaccharide (LPS) by
CC       phosphorylating a number of transcription factors, such as ELK1
CC       and ATF2 and several downstream kinases, such as MAPKAPK2 and
CC       MAPKAPK5. Plays a critical role in the production of some
CC       cytokines, for example IL-6. May play a role in stabilization of
CC       EPO mRNA during hypoxic stress. Isoform Mxi2 activation is
CC       stimulated by mitogens and oxidative stress and only poorly
CC       phosphorylates ELK1 and ATF2. Isoform Exip may play a role in the
CC       early onset of apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by either of two dual specificity kinases, MAP2K3
CC       or MAP2K6, and potentially also MAP2K4. Inhibited by dual
CC       specificity phosphatases, such as DUSP1. Specifically inhibited by
CC       the binding of pyridinyl-imidazole compounds, which are cytokine-
CC       suppressive anti-inflammatory drugs (CSAID). Isoform Mxi2 is 100-
CC       fold less sensitive to these agents than the other isoforms and is
CC       not inhibited by DUSP1. Isoform Exip is not activated by MAP2K6.
CC   -!- SUBUNIT: Binds to a kinase interaction motif within the protein
CC       tyrosine phosphatase, PTPRR. This interaction retains MAPK14 in
CC       the cytoplasm and prevents nuclear accumulation. Interacts with
CC       SPAG9 (By similarity). Interacts with NP60 and FAM48A.
CC   -!- INTERACTION:
CC       Q8NEM7:FAM48A; NbExp=2; IntAct=EBI-73946, EBI-946984;
CC       P09211:GSTP1; NbExp=1; IntAct=EBI-73946, EBI-353467;
CC       P49137:MAPKAPK2; NbExp=1; IntAct=EBI-73946, EBI-993299;
CC       Q16512:PKN1; NbExp=1; IntAct=EBI-73946, EBI-602382;
CC       O75676:RPS6KA4; NbExp=1; IntAct=EBI-73946, EBI-73933;
CC       Q92574:TSC1; NbExp=1; IntAct=EBI-73946, EBI-1047085;
CC       Q07352:ZFP36L1; NbExp=1; IntAct=EBI-73946, EBI-721823;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=CSBP2;
CC         IsoId=Q16539-1; Sequence=Displayed;
CC       Name=CSBP1;
CC         IsoId=Q16539-2; Sequence=VSP_004842;
CC       Name=Mxi2;
CC         IsoId=Q16539-3; Sequence=VSP_004844;
CC       Name=Exip; Synonyms=Exon skip;
CC         IsoId=Q16539-4; Sequence=VSP_004843, VSP_004845;
CC   -!- TISSUE SPECIFICITY: Brain, heart, placenta, pancreas and skeletal
CC       muscle. Expressed to a lesser extent in lung, liver and kidney.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-180 and Tyr-182, which activates
CC       the enzyme.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P38 mitogen-activated protein
CC       kinases entry;
CC       URL="http://en.wikipedia.org/wiki/P38_mitogen-activated_protein_kinases";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L35263; AAA57455.1; -; mRNA.
DR   EMBL; L35264; AAA57456.1; -; mRNA.
DR   EMBL; L35253; AAA74301.1; -; mRNA.
DR   EMBL; U19775; AAC50329.1; -; mRNA.
DR   EMBL; AF100544; AAF36770.1; -; mRNA.
DR   EMBL; AB074150; BAB85654.1; -; mRNA.
DR   EMBL; AK291709; BAF84398.1; -; mRNA.
DR   EMBL; BT006933; AAP35579.1; -; mRNA.
DR   EMBL; CR536505; CAG38743.1; -; mRNA.
DR   EMBL; EU332860; ABY87549.1; -; Genomic_DNA.
DR   EMBL; Z95152; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03869.1; -; Genomic_DNA.
DR   EMBL; BC000092; AAH00092.1; -; mRNA.
DR   EMBL; BC031574; AAH31574.1; -; mRNA.
DR   IPI; IPI00002857; -.
DR   IPI; IPI00221141; -.
DR   IPI; IPI00221142; -.
DR   IPI; IPI00221143; -.
DR   PIR; S53536; S53536.
DR   RefSeq; NP_001306.1; -.
DR   RefSeq; NP_620581.1; -.
DR   RefSeq; NP_620582.1; -.
DR   RefSeq; NP_620583.1; -.
DR   UniGene; Hs.485233; -.
DR   UniGene; Hs.719314; -.
DR   UniGene; Hs.722031; -.
DR   PDB; 1A9U; X-ray; 2.50 A; A=1-360.
DR   PDB; 1BL6; X-ray; 2.50 A; A=1-360.
DR   PDB; 1BL7; X-ray; 2.50 A; A=1-360.
DR   PDB; 1BMK; X-ray; 2.40 A; A=1-360.
DR   PDB; 1DI9; X-ray; 2.60 A; A=1-360.
DR   PDB; 1IAN; X-ray; 2.00 A; A=2-360.
DR   PDB; 1KV1; X-ray; 2.50 A; A=1-360.
DR   PDB; 1KV2; X-ray; 2.80 A; A=1-360.
DR   PDB; 1M7Q; X-ray; 2.40 A; A=1-360.
DR   PDB; 1OUK; X-ray; 2.50 A; A=1-360.
DR   PDB; 1OUY; X-ray; 2.50 A; A=1-360.
DR   PDB; 1OVE; X-ray; 2.10 A; A=1-360.
DR   PDB; 1OZ1; X-ray; 2.10 A; A=1-360.
DR   PDB; 1R39; X-ray; 2.30 A; A=1-360.
DR   PDB; 1R3C; X-ray; 2.00 A; A=1-360.
DR   PDB; 1W7H; X-ray; 2.21 A; A=2-359.
DR   PDB; 1W82; X-ray; 2.20 A; A=2-359.
DR   PDB; 1W83; X-ray; 2.50 A; A=2-359.
DR   PDB; 1W84; X-ray; 2.20 A; A=2-359.
DR   PDB; 1WBN; X-ray; 2.40 A; A=2-359.
DR   PDB; 1WBO; X-ray; 2.16 A; A=2-359.
DR   PDB; 1WBS; X-ray; 1.80 A; A=2-359.
DR   PDB; 1WBT; X-ray; 2.00 A; A=2-359.
DR   PDB; 1WBV; X-ray; 2.00 A; A=2-359.
DR   PDB; 1WBW; X-ray; 2.41 A; A=2-359.
DR   PDB; 1WFC; X-ray; 2.30 A; A=1-360.
DR   PDB; 1YQJ; X-ray; 2.00 A; A=2-359.
DR   PDB; 1ZYJ; X-ray; 2.00 A; A=1-360.
DR   PDB; 1ZZ2; X-ray; 2.00 A; A=1-360.
DR   PDB; 1ZZL; X-ray; 2.00 A; A=4-353.
DR   PDB; 2BAJ; X-ray; 2.25 A; A=2-359.
DR   PDB; 2BAK; X-ray; 2.20 A; A=2-359.
DR   PDB; 2BAL; X-ray; 2.10 A; A=2-359.
DR   PDB; 2BAQ; X-ray; 2.80 A; A=2-359.
DR   PDB; 2FSL; X-ray; 1.70 A; X=2-359.
DR   PDB; 2FSM; X-ray; 1.86 A; X=2-359.
DR   PDB; 2FSO; X-ray; 1.83 A; X=2-359.
DR   PDB; 2FST; X-ray; 1.45 A; X=2-359.
DR   PDB; 2GFS; X-ray; 1.75 A; A=2-359.
DR   PDB; 2I0H; X-ray; 2.00 A; A=1-360.
DR   PDB; 2NPQ; X-ray; 1.80 A; A=2-359.
DR   PDB; 2OKR; X-ray; 2.00 A; A/D=2-359.
DR   PDB; 2ONL; X-ray; 4.00 A; A/B=2-359.
DR   PDB; 2QD9; X-ray; 1.70 A; A=2-360.
DR   PDB; 2RG5; X-ray; 2.40 A; A=2-360.
DR   PDB; 2RG6; X-ray; 1.72 A; A=2-360.
DR   PDB; 2ZAZ; X-ray; 1.80 A; A=1-360.
DR   PDB; 2ZB0; X-ray; 2.10 A; A=1-360.
DR   PDB; 2ZB1; X-ray; 2.50 A; A=1-360.
DR   PDB; 3BV2; X-ray; 2.40 A; A=2-360.
DR   PDB; 3BV3; X-ray; 2.59 A; A=2-360.
DR   PDB; 3BX5; X-ray; 2.40 A; A=2-360.
DR   PDB; 3C5U; X-ray; 2.80 A; A=2-360.
DR   PDB; 3CTQ; X-ray; 1.95 A; A=5-352.
DR   PDB; 3D7Z; X-ray; 2.10 A; A=1-360.
DR   PDB; 3D83; X-ray; 1.90 A; A=1-360.
DR   PDB; 3DS6; X-ray; 2.90 A; A/B/C/D=1-360.
DR   PDB; 3DT1; X-ray; 2.80 A; A=1-360.
DR   PDB; 3E92; X-ray; 2.00 A; A=1-360.
DR   PDB; 3E93; X-ray; 2.00 A; A=1-360.
DR   PDB; 3FC1; X-ray; 2.40 A; X=1-360.
DR   PDB; 3FI4; X-ray; 2.20 A; A=1-360.
DR   PDB; 3FKL; X-ray; 2.00 A; A=1-360.
DR   PDB; 3FKN; X-ray; 2.00 A; A=1-360.
DR   PDB; 3FKO; X-ray; 2.00 A; A=1-360.
DR   PDB; 3FL4; X-ray; 1.80 A; A=1-360.
DR   PDB; 3FLN; X-ray; 1.90 A; C=1-360.
DR   PDB; 3FLQ; X-ray; 1.90 A; A=1-360.
DR   PDB; 3FLS; X-ray; 2.30 A; A=1-360.
DR   PDB; 3FLW; X-ray; 2.10 A; A=1-360.
DR   PDB; 3FLY; X-ray; 1.80 A; A=1-360.
DR   PDB; 3FLZ; X-ray; 2.23 A; A=1-360.
DR   PDB; 3FMH; X-ray; 1.90 A; A=1-360.
DR   PDB; 3FMJ; X-ray; 2.00 A; A=1-360.
DR   PDB; 3FMK; X-ray; 1.70 A; A=1-360.
DR   PDB; 3FML; X-ray; 2.10 A; A=1-360.
DR   PDB; 3FMM; X-ray; 2.00 A; A=1-360.
DR   PDB; 3FMN; X-ray; 1.90 A; A=1-360.
DR   PDB; 3FSF; X-ray; 2.10 A; A=1-360.
DR   PDB; 3FSK; X-ray; 2.00 A; A=1-360.
DR   PDB; 3GC7; X-ray; 1.80 A; A=1-360.
DR   PDB; 3GCP; X-ray; 2.25 A; A=2-360.
DR   PDB; 3GCQ; X-ray; 2.00 A; A=2-360.
DR   PDB; 3GCS; X-ray; 2.10 A; A=2-360.
DR   PDB; 3GCU; X-ray; 2.10 A; A/B=2-360.
DR   PDB; 3GCV; X-ray; 2.30 A; A=2-360.
DR   PDB; 3GFE; X-ray; 2.10 A; A=1-360.
DR   PDB; 3GI3; X-ray; 2.40 A; A=1-360.
DR   PDB; 3HA8; X-ray; 2.48 A; A=1-360.
DR   PDB; 3HEC; X-ray; 2.50 A; A=5-352.
DR   PDB; 3HEG; X-ray; 2.20 A; A=5-352.
DR   PDB; 3HL7; X-ray; 1.88 A; A=1-360.
DR   PDB; 3HLL; X-ray; 1.95 A; A=1-360.
DR   PDB; 3HP2; X-ray; 2.15 A; A=1-360.
DR   PDB; 3HP5; X-ray; 2.30 A; A=1-360.
DR   PDB; 3HRB; X-ray; 2.20 A; A=2-360.
DR   PDB; 3HUB; X-ray; 2.25 A; A=2-360.
DR   PDB; 3HUC; X-ray; 1.80 A; A=2-360.
DR   PDB; 3HV3; X-ray; 2.00 A; A=2-360.
DR   PDB; 3HV4; X-ray; 2.60 A; A/B=2-360.
DR   PDB; 3HV5; X-ray; 2.25 A; A/B=2-360.
DR   PDB; 3HV6; X-ray; 1.95 A; A=2-360.
DR   PDB; 3HV7; X-ray; 2.40 A; A=2-360.
DR   PDB; 3HVC; X-ray; 2.10 A; A=1-360.
DR   PDB; 3IPH; X-ray; 2.10 A; A=1-360.
DR   PDB; 3ITZ; X-ray; 2.25 A; A=1-360.
DR   PDB; 3IW5; X-ray; 2.50 A; A=2-360.
DR   PDB; 3IW6; X-ray; 2.10 A; A=2-360.
DR   PDB; 3IW7; X-ray; 2.40 A; A=2-360.
DR   PDB; 3IW8; X-ray; 2.00 A; A=2-360.
DR   PDB; 3K3I; X-ray; 1.70 A; A=5-352.
DR   PDB; 3K3J; X-ray; 2.00 A; A=1-360.
DR   PDB; 3KF7; X-ray; 2.00 A; A=1-360.
DR   PDB; 3KQ7; X-ray; 1.80 A; A=1-360.
DR   PDB; 3L8S; X-ray; 2.35 A; A=2-360.
DR   PDB; 3L8X; X-ray; 2.15 A; A=2-360.
DR   PDB; 3LHJ; X-ray; 3.31 A; A=1-360.
DR   PDB; 3MGY; X-ray; 2.10 A; A=1-360.
DR   PDB; 3MH0; X-ray; 2.00 A; A=1-360.
DR   PDB; 3MH1; X-ray; 2.20 A; A=1-360.
DR   PDB; 3MH2; X-ray; 2.30 A; A=1-360.
DR   PDB; 3MH3; X-ray; 2.20 A; A=1-360.
DR   PDB; 3MPA; X-ray; 2.10 A; A=1-360.
DR   PDB; 3MPT; X-ray; 1.89 A; A=1-360.
DR   PDB; 3NNU; X-ray; 2.40 A; A=1-354.
DR   PDB; 3NNV; X-ray; 2.10 A; A=1-354.
DR   PDB; 3NNW; X-ray; 1.89 A; A=1-354.
DR   PDB; 3NNX; X-ray; 2.28 A; A=1-354.
DR   PDB; 3NWW; X-ray; 2.09 A; A=2-360.
DR   PDB; 3O8P; X-ray; 2.10 A; A=1-360.
DR   PDB; 3O8U; X-ray; 2.10 A; A=1-360.
DR   PDB; 3OBG; X-ray; 2.80 A; A=1-360.
DR   PDB; 3OBJ; X-ray; 2.40 A; A=1-360.
DR   PDB; 3OC1; X-ray; 2.59 A; A=1-360.
DR   PDBsum; 1A9U; -.
DR   PDBsum; 1BL6; -.
DR   PDBsum; 1BL7; -.
DR   PDBsum; 1BMK; -.
DR   PDBsum; 1DI9; -.
DR   PDBsum; 1IAN; -.
DR   PDBsum; 1KV1; -.
DR   PDBsum; 1KV2; -.
DR   PDBsum; 1M7Q; -.
DR   PDBsum; 1OUK; -.
DR   PDBsum; 1OUY; -.
DR   PDBsum; 1OVE; -.
DR   PDBsum; 1OZ1; -.
DR   PDBsum; 1R39; -.
DR   PDBsum; 1R3C; -.
DR   PDBsum; 1W7H; -.
DR   PDBsum; 1W82; -.
DR   PDBsum; 1W83; -.
DR   PDBsum; 1W84; -.
DR   PDBsum; 1WBN; -.
DR   PDBsum; 1WBO; -.
DR   PDBsum; 1WBS; -.
DR   PDBsum; 1WBT; -.
DR   PDBsum; 1WBV; -.
DR   PDBsum; 1WBW; -.
DR   PDBsum; 1WFC; -.
DR   PDBsum; 1YQJ; -.
DR   PDBsum; 1ZYJ; -.
DR   PDBsum; 1ZZ2; -.
DR   PDBsum; 1ZZL; -.
DR   PDBsum; 2BAJ; -.
DR   PDBsum; 2BAK; -.
DR   PDBsum; 2BAL; -.
DR   PDBsum; 2BAQ; -.
DR   PDBsum; 2FSL; -.
DR   PDBsum; 2FSM; -.
DR   PDBsum; 2FSO; -.
DR   PDBsum; 2FST; -.
DR   PDBsum; 2GFS; -.
DR   PDBsum; 2I0H; -.
DR   PDBsum; 2NPQ; -.
DR   PDBsum; 2OKR; -.
DR   PDBsum; 2ONL; -.
DR   PDBsum; 2QD9; -.
DR   PDBsum; 2RG5; -.
DR   PDBsum; 2RG6; -.
DR   PDBsum; 2ZAZ; -.
DR   PDBsum; 2ZB0; -.
DR   PDBsum; 2ZB1; -.
DR   PDBsum; 3BV2; -.
DR   PDBsum; 3BV3; -.
DR   PDBsum; 3BX5; -.
DR   PDBsum; 3C5U; -.
DR   PDBsum; 3CTQ; -.
DR   PDBsum; 3D7Z; -.
DR   PDBsum; 3D83; -.
DR   PDBsum; 3DS6; -.
DR   PDBsum; 3DT1; -.
DR   PDBsum; 3E92; -.
DR   PDBsum; 3E93; -.
DR   PDBsum; 3FC1; -.
DR   PDBsum; 3FI4; -.
DR   PDBsum; 3FKL; -.
DR   PDBsum; 3FKN; -.
DR   PDBsum; 3FKO; -.
DR   PDBsum; 3FL4; -.
DR   PDBsum; 3FLN; -.
DR   PDBsum; 3FLQ; -.
DR   PDBsum; 3FLS; -.
DR   PDBsum; 3FLW; -.
DR   PDBsum; 3FLY; -.
DR   PDBsum; 3FLZ; -.
DR   PDBsum; 3FMH; -.
DR   PDBsum; 3FMJ; -.
DR   PDBsum; 3FMK; -.
DR   PDBsum; 3FML; -.
DR   PDBsum; 3FMM; -.
DR   PDBsum; 3FMN; -.
DR   PDBsum; 3FSF; -.
DR   PDBsum; 3FSK; -.
DR   PDBsum; 3GC7; -.
DR   PDBsum; 3GCP; -.
DR   PDBsum; 3GCQ; -.
DR   PDBsum; 3GCS; -.
DR   PDBsum; 3GCU; -.
DR   PDBsum; 3GCV; -.
DR   PDBsum; 3GFE; -.
DR   PDBsum; 3GI3; -.
DR   PDBsum; 3HA8; -.
DR   PDBsum; 3HEC; -.
DR   PDBsum; 3HEG; -.
DR   PDBsum; 3HL7; -.
DR   PDBsum; 3HLL; -.
DR   PDBsum; 3HP2; -.
DR   PDBsum; 3HP5; -.
DR   PDBsum; 3HRB; -.
DR   PDBsum; 3HUB; -.
DR   PDBsum; 3HUC; -.
DR   PDBsum; 3HV3; -.
DR   PDBsum; 3HV4; -.
DR   PDBsum; 3HV5; -.
DR   PDBsum; 3HV6; -.
DR   PDBsum; 3HV7; -.
DR   PDBsum; 3HVC; -.
DR   PDBsum; 3IPH; -.
DR   PDBsum; 3ITZ; -.
DR   PDBsum; 3IW5; -.
DR   PDBsum; 3IW6; -.
DR   PDBsum; 3IW7; -.
DR   PDBsum; 3IW8; -.
DR   PDBsum; 3K3I; -.
DR   PDBsum; 3K3J; -.
DR   PDBsum; 3KF7; -.
DR   PDBsum; 3KQ7; -.
DR   PDBsum; 3L8S; -.
DR   PDBsum; 3L8X; -.
DR   PDBsum; 3LHJ; -.
DR   PDBsum; 3MGY; -.
DR   PDBsum; 3MH0; -.
DR   PDBsum; 3MH1; -.
DR   PDBsum; 3MH2; -.
DR   PDBsum; 3MH3; -.
DR   PDBsum; 3MPA; -.
DR   PDBsum; 3MPT; -.
DR   PDBsum; 3NNU; -.
DR   PDBsum; 3NNV; -.
DR   PDBsum; 3NNW; -.
DR   PDBsum; 3NNX; -.
DR   PDBsum; 3NWW; -.
DR   PDBsum; 3O8P; -.
DR   PDBsum; 3O8U; -.
DR   PDBsum; 3OBG; -.
DR   PDBsum; 3OBJ; -.
DR   PDBsum; 3OC1; -.
DR   ProteinModelPortal; Q16539; -.
DR   IntAct; Q16539; 37.
DR   MINT; MINT-126546; -.
DR   STRING; Q16539; -.
DR   PhosphoSite; Q16539; -.
DR   OGP; Q16539; -.
DR   PRIDE; Q16539; -.
DR   Ensembl; ENST00000229794; ENSP00000229794; ENSG00000112062.
DR   GeneID; 1432; -.
DR   KEGG; hsa:1432; -.
DR   UCSC; uc003olo.1; human.
DR   UCSC; uc003olp.1; human.
DR   UCSC; uc003olq.1; human.
DR   UCSC; uc003olr.1; human.
DR   CTD; 1432; -.
DR   GeneCards; GC06P036042; -.
DR   HGNC; HGNC:6876; MAPK14.
DR   HPA; CAB010285; -.
DR   MIM; 600289; gene.
DR   PharmGKB; PA30621; -.
DR   eggNOG; prNOG10871; -.
DR   HOVERGEN; HBG014652; -.
DR   OMA; KTEWEVP; -.
DR   PhylomeDB; Q16539; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Pathway_Interaction_DB; nfkappabatypicalpathway; Atypical NF-kappaB pathway.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; epopathway; EPO signaling pathway.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; il4_2pathway; IL4-mediated signaling events.
DR   Pathway_Interaction_DB; il6_7pathway; IL6-mediated signaling events.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; ar_tf_pathway; Regulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; retinoic_acid_pathway; Retinoic acid receptors-mediated signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; s1p_s1p2_pathway; S1P2 pathway.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
DR   Pathway_Interaction_DB; lymphangiogenesis_pathway; VEGFR3 signaling in lymphatic endothelium.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_21303; Myogenesis.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 5841; -.
DR   ArrayExpress; Q16539; -.
DR   Bgee; Q16539; -.
DR   CleanEx; HS_MAPK14; -.
DR   Genevestigator; Q16539; -.
DR   GermOnline; ENSG00000112062; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0008339; F:MP kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0007166; P:cell surface receptor linked signaling pathway; TAS:ProtInc.
DR   GO; GO:0006928; P:cellular component movement; TAS:ProtInc.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007265; P:Ras protein signal transduction; EXP:Reactome.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR008352; MAPK_p38.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01773; P38MAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    360       Mitogen-activated protein kinase 14.
FT                                /FTId=PRO_0000186291.
FT   DOMAIN       24    308       Protein kinase.
FT   NP_BIND      30     38       ATP.
FT   MOTIF       180    182       TXY.
FT   ACT_SITE    168    168       Proton acceptor.
FT   BINDING      53     53       ATP.
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES      16     16       Phosphothreonine.
FT   MOD_RES     180    180       Phosphothreonine.
FT   MOD_RES     182    182       Phosphotyrosine.
FT   MOD_RES     263    263       Phosphothreonine.
FT   VAR_SEQ     230    254       DQLKLILRLVGTPGAELLKKISSES -> NQLQQIMRLTGT
FT                                PPAYLINRMPSHE (in isoform CSBP1).
FT                                /FTId=VSP_004842.
FT   VAR_SEQ     255    307       ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK
FT                                RITAAQALAHAY -> LSTCWRRCLYWTQIRELQRPKPLHM
FT                                PTLLSTTILMMNQWPILMISPLKAGTSL (in isoform
FT                                Exip).
FT                                /FTId=VSP_004843.
FT   VAR_SEQ     281    360       AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD
FT                                PYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
FT                                -> GKLTIYPHLMDIELVMI (in isoform Mxi2).
FT                                /FTId=VSP_004844.
FT   VAR_SEQ     308    360       Missing (in isoform Exip).
FT                                /FTId=VSP_004845.
FT   VARIANT      51     51       A -> V (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042270.
FT   VARIANT     322    322       P -> R (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042271.
FT   VARIANT     343    343       D -> G (in dbSNP:rs45496794).
FT                                /FTId=VAR_042272.
FT   MUTAGEN      34     34       A->V: Lowered kinase activity.
FT   MUTAGEN      53     53       K->R: Loss of kinase activity.
FT   MUTAGEN      69     69       Y->H: Lowered kinase activity.
FT   MUTAGEN     168    168       D->A: Loss of kinase activity.
FT   MUTAGEN     175    175       T->A: Loss of kinase activity.
FT   MUTAGEN     176    176       D->A: Emulation of the active state.
FT                                Increase in activity; when associated
FT                                with S-327 or L-327.
FT   MUTAGEN     177    177       D->A: Loss of kinase activity.
FT   MUTAGEN     180    180       T->E: Loss of kinase activity.
FT   MUTAGEN     182    182       Y->F: Loss of kinase activity.
FT   MUTAGEN     320    320       A->T: Lowered kinase activity.
FT   MUTAGEN     327    327       F->L: Emulation of the active state.
FT                                Increase in activity; when associated
FT                                with A-176.
FT   MUTAGEN     327    327       F->S: Emulation of the active state.
FT                                Increase in activity; when associated
FT                                with A-176.
FT   MUTAGEN     337    337       W->R: Loss of kinase activity.
FT   CONFLICT     67     67       R -> G (in Ref. 6; BAF84398).
FT   STRAND        8     13
FT   STRAND       16     21
FT   STRAND       24     29
FT   STRAND       38     43
FT   TURN         44     47
FT   STRAND       48     54
FT   HELIX        62     77
FT   STRAND       87     90
FT   HELIX        96     98
FT   STRAND      103    107
FT   HELIX       124    143
FT   HELIX       153    155
FT   STRAND      156    158
FT   STRAND      164    166
FT   HELIX       191    194
FT   HELIX       204    218
FT   HELIX       228    239
FT   HELIX       244    247
FT   HELIX       253    260
FT   HELIX       270    273
FT   TURN        274    276
FT   HELIX       279    288
FT   HELIX       293    295
FT   HELIX       299    303
FT   HELIX       306    308
FT   TURN        309    311
FT   HELIX       314    316
FT   HELIX       325    327
FT   HELIX       334    347
SQ   SEQUENCE   360 AA;  41293 MW;  286C81D0487618B3 CRC64;
     MSQERPTFYR QELNKTIWEV PERYQNLSPV GSGAYGSVCA AFDTKTGLRV AVKKLSRPFQ
     SIIHAKRTYR ELRLLKHMKH ENVIGLLDVF TPARSLEEFN DVYLVTHLMG ADLNNIVKCQ
     KLTDDHVQFL IYQILRGLKY IHSADIIHRD LKPSNLAVNE DCELKILDFG LARHTDDEMT
     GYVATRWYRA PEIMLNWMHY NQTVDIWSVG CIMAELLTGR TLFPGTDHID QLKLILRLVG
     TPGAELLKKI SSESARNYIQ SLTQMPKMNF ANVFIGANPL AVDLLEKMLV LDSDKRITAA
     QALAHAYFAQ YHDPDDEPVA DPYDQSFESR DLLIDEWKSL TYDEVISFVP PPLDQEEMES
//
